Zydus Cadila has received approval from the US health regulator to market Doxazosin tablets, used for treatment of high blood pressure and urinary retention associated with enlargement of the prostate ...

MAPLE GROVE, Minn., May 1, 2018 /PRNewswire/ -- Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced the launch of Doxazosin Tablets, USP, 1 mg, 2 mg, 4 mg and 8 mg. The product was approved ...

The Price section compares costs of the same generic drugs across brands and is purely for information purpose. Medindia neither buys nor sells drugs. Doxazosin (Duraten) is an alpha blocker, ...

At midday on January 11, the share price of Unichem Laboratories reached a 52-week high of Rs 479.25 following the approval of a generic version of a hypertension medication by the US Food and Drug ...

The Unichem Laboratories share price touched a 52-week high of Rs 479.25 at noon on January 11 after the company received United States Food and Drug Administration's nod for the generic version of a ...

In our study, after 6 months of treatment, all acarbose-treated patients experienced a significant reduction in BMI (-3.6%), HbA 1c (-9.9%), FPG (-8.4%) and PPG (-16.3%); however, only those patients ...

The company "has received the final approval from the United States Food and Drug Administration (USFDA) to market Doxazosin tablets USP, 1 mg, 2 mg, 4 mg, and 8 mg", Zydus Cadila said in a statement.

The Price section compares costs of the same generic drugs across brands and is purely for information purpose. Medindia neither buys nor sells drugs. Doxazosin (Doxa) is an alpha blocker, prescribed ...